evaluate the pharmaceuticals company saxenda on glp-1 medications (liraglutide) evaluate the pharmaceuticals company saxenda

This is surprising if you tolerated tirzepatide without issues, as semaglutide typically causes fewer side effects

August 9th, 2025: Lawsuits Mount Over Vision Loss Risks Linked to Ozempic, Wegovy, and Mounjaro New research has suggested a possible connection between GLP-1 receptor agonist drugsincluding Ozempic, Wegovy, and Mounjaroand heightened risks of severe eye conditions such as neovascular age-related macular degeneration (nAMD) and nonarteritic anterior ischemic optic neuropathy (NAION)

Validation of a self-administered diet history questionnaire using multiple diet records

Currently, no federal law explicitly bars weight-based discrimination, and most federal appeals courts have held that obesity (unless caused by an underlying health condition) is not a protected disability under the ADA

J Am Pharm Assoc (2003) 2023;63(5):16121616

The Benefits of Strength Training Post-Weight Loss At Done Done, we focus on transitioning our clients from skinny to strong